ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIV

By Yahoo! Finance | Nov 12, 2024 at 05:30 AM EST

ViiV Healthcare presented results from the DOLCE trial, showing Dovato's efficacy in treating advanced HIV comparable to a three-drug therapy. The study demonstrated similar viral suppression rates and safety profiles in patients with low CD4 counts.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.